---
title: "NNT"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene: NNT"
tags: ['NNT', 'FamilialGlucocorticoidDeficiency', 'Mitochondria', 'EnergyMetabolism', 'MissenseMutation', 'HormoneReplacementTherapy', 'Prognosis', 'DrugResponse']
---

# Gene: NNT

## Information:
- **Pathology:** The NNT gene is associated with familial glucocorticoid deficiency type 2 (FGD2) which is a disorder characterized by adrenal insufficiency.
- **Function:** The NNT gene encodes a protein called nicotinamide nucleotide transhydrogenase, which participates in energy metabolism in mitochondria.
- **External IDs and Aliases:** 
 - HGNC: 7839 
 - NCBI Entrez: 23,506 
 - Ensembl: ENSG00000134108 
 - OMIM: 602,085 
 - UniProtKB/Swiss-Prot: Q13423
 - Aliases: FGD4, PNC1 

## Variants:
- **AA Mutation List with dbSNP ID:**
  - p.Arg34His (rs56208167)  
  - p.Ala12Val (rs369693408)
  - p.Glu373Asp (rs200745524)
- **Mutation Type:** Missense

- **Somatic SNVs/InDels with dbSNP ID:**
  - rs74983580
  - rs587777153
  - rs187455881

## Related Diseases:
- Familial glucocorticoid deficiency type 2

## Treatment and Prognosis
- Treatment includes hormone replacement therapy to manage adrenal insufficiency symptoms.
- Prognosis is generally good with appropriate treatment.

## Drug Response:
- There are currently no known drugs specifically targeting NNT.

## References:
- Meimaridou E, et al. (2012) "Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency." Nat Genet 44(7): 740-742. PMID: 22729223 
- UniProtKB/Swiss-Prot: Q13423.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**